Injection Pen Packaging, Labeling and UDI Project Guide

Reviewed September 21, 2026 · For B2B procurement and development teams

Key parameters to define

• Pack contents and packaging levels
• Legal manufacturer or device labeler
• Target countries and language set
• UDI/identifier issuing and database roles
• Lot, serial and date requirements
• Artwork version and translation control
• Print, scan and release inspection criteria

Freeze the pack architecture before artwork

Define what is supplied: pen only, pen plus needle, cartridge system, accessories, case, training item or a co-packaged combination. Identify primary, secondary and shipping packaging, protection needs, cleanliness or sterile barriers where applicable, shelf-life assumptions, count per pack and distribution conditions. Artwork cannot be finalized until the legal manufacturer or labeler, intended use, model, warnings, symbols, language set and market route are known. A private-label request may change who appears on the label and who holds regulatory responsibilities; it is not simply a logo replacement. Packaging samples should be marked as mockups until content, materials, print methods and inspection criteria are approved through the project change-control process. Document the decision, evidence status, responsible owner and unresolved assumptions so later project changes can be reviewed against a stable baseline.

Plan UDI and variable data by market role

In the United States, the FDA UDI system generally requires the device labeler to place a unique device identifier on device labels and packages unless an exception or alternative applies, and to submit device information to GUDID. A UDI commonly includes a fixed device identifier and conditional production identifiers such as lot, serial number, expiration date or manufacture date. The responsible labeler, issuing agency, data carrier, human-readable text, packaging levels and database submission must be determined for the actual device. Other markets have their own identification and registration requirements. An OEM supplier can implement approved variable-data production, but the customer and responsible regulatory parties must provide and control the authorized identifiers and content. Write acceptance criteria before testing so observations remain traceable to an approved requirement rather than being interpreted only after the result.

Control artwork, printing and release

Use a controlled artwork specification with version, dimensions, colors, fonts, symbols, barcode or data-matrix parameters, language content and approval signatures. Verification should include legibility, contrast, adhesion or durability, scan performance where applicable, variable-data accuracy and reconciliation. The bill of material and production records should link the released artwork to the correct device and pack level. Define who approves translations and regulatory text, how obsolete versions are removed and what happens when an identifier, address, instruction or market requirement changes. Packaging inspection should be tied to the approved specification, not an email attachment. For an RFQ, state all countries, languages, packaging levels, expected annual quantities and serialization or variable-data needs so setup cost and MOQ can be quoted accurately. Record the output, approval owner and change triggers in the project file so procurement, engineering, quality and regulatory teams use the same baseline.

Related technical paths

OEM/ODM Services · Understanding Injection Pen MOQ · Wholesale Injection Pens

Sources and verification

Use the primary sources below to verify the current requirement and its scope. Requirements can change by device, role, market and version; this guide was reviewed on September 21, 2026.

• FDA — UDI Basics
• FDA — Device Labeling

Questions buyers also ask